fig5
From: Peritoneal mesothelioma
Figure 5. Serum CA125, hyaluronic acid, and SMRP levels during nivolumab treatment in a recurrent mesothelioma patient.
Journal of Cancer Metastasis and Treatment
ISSN 2454-2857 (Online) 2394-4722 (Print)
Navigation
Follow Us
Navigation
Portico
All published articles are preserved here permanently:
https://www.portico.org/publishers/oae/
Follow OAE
